
Kryporab L 75mg/20mg Capsule SR
Marketer
Kryptomed Formulations Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Kryporab L 75mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome can be treated with the prescription medication, Kryporab L 75mg/20mg Sustained-Release Capsules. This medication lessens excessive stomach acid production and prevents its backflow into the esophagus. Dosage and duration for Kryporab L 75mg/20mg SR Capsules are determined by your physician and may be taken with or without food. Treatment should continue as directed; premature cessation may lead to symptom recurrence and condition worsening. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include nausea, abdominal pain, diarrhea, gas, constipation, headache, fatigue, and flu-like symptoms – most are transient. Report any concerning side effects immediately. Dizziness and drowsiness are potential side effects; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. A fiber-rich diet, avoidance of trigger foods, increased hydration, and regular exercise can enhance treatment outcomes. Prior to commencing treatment, disclose any kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Primary Ingredients of Kryporab L 75mg/20mg Capsule SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Kryporab L 75mg/20mg Capsule SR
Managing intestinal ulcers, irritable bowel syndrome, and gastroesophageal reflux disease (GERD).
Major Benefits of Kryporab L 75mg/20mg Capsule SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire capsule without chewing, crushing, or breaking it. Kryporab L 75mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
Common Side effects of Kryporab L 75mg/20mg Capsule SR:
- Weakness
- Flatulence
- Vomiting
- Nausea
- Abdominal pain
- Diarrhea
- Headache
- Dizziness
- Breast enlargement in male
- Drowsiness
- Altered libido
- Absence of menstrual periods
- Unusual production of breast milk in women and men
- Cough
- Back pain
How to use Kryporab L 75mg/20mg Capsule SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Consume Kryporab L 75mg/20mg sustained-release capsules on an empty stomach.
How Kryporab L 75mg/20mg Capsule SR works:
Levosulpiride, a gastrointestinal motility stimulant, enhances acetylcholine release, boosting stomach and intestinal contractions and thereby suppressing reflux. Rabeprazole, a proton pump inhibitor, decreases stomach acid production, alleviating acid-induced indigestion and ulcers.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant alcohol consumption with Kryporab L 75mg/20mg SR Capsules is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Kryporab L 75mg/20mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Kryporab L 75mg/20mg sustained-release capsules while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Kryporab L 75mg/20mg SR Capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kryporab L 75mg/20mg sustained-release capsules to individuals with renal impairment. Physician consultation is advised. Preliminary findings, however, indicate that this medication should be used cautiously in such patients.
LiverCAUTION
Exercise caution when administering Kryporab L 75mg/20mg sustained-release capsules to individuals suffering from severe hepatic impairment. Dosage modification of Kryporab L 75mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Kryporab L 75mg/20mg Capsule SR :
Should you forget to take a Kryporab L 75mg/20mg Capsule SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Kryporab L 75mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
